In vitro and in vivo synergistic activity of colistin, rifampin, and amikacin against a multiresistant Pseudomonas aeruginosa isolate

Clin Microbiol Infect. 2000 Dec;6(12):690-1. doi: 10.1046/j.1469-0691.2000.00169.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amikacin / therapeutic use*
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotics, Antitubercular / therapeutic use
  • Colistin / therapeutic use*
  • Drug Resistance, Multiple*
  • Drug Therapy, Combination / therapeutic use*
  • Humans
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pseudomonas Infections / drug therapy*
  • Rifampin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Antibiotics, Antitubercular
  • Amikacin
  • Rifampin
  • Colistin